/

Intellia Therapeutics

Develops curative gene-editing treatments using CRISPR technology.

Biotechnology intelliatx.com ↗

Company facts

Founded: 2014
Employees: 656
Headquarters: United States
Type: Public
Listed: NASDAQ: NTLA
Subsidiaries: eXtellia Therapeutics